Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Commentary on: "Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss", by G. R. W. Moore, et al. in J Neurol (2008) 255: DOI 10.1007/s00415-008-0002-z.
[Multiple sclerosis and microRNA].
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.
Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study.
Optimized T1-MPRAGE Sequence for Better Visualization of Spinal Cord Multiple Sclerosis Lesions at 3T.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
Evaluation of Rho-Kinase Activity in Mice Brain Using N-[(11)C]Methyl-hydroxyfasudil with Positron Emission Tomography.
[Treatment of multiple sclerosis: new approaches to treat case by case].
Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
Antiretrovirals inhibit arginase in human microglia.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients.
Diffusion-weighted imaging as an aid in the diagnosis of the etiology of medial longitudinal fasciculus syndrome.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
Assessing intracortical myelin in the living human brain using myelinated cortical thickness.
The quality of primary health care for chronically ill patients: a cross-sectional study.
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.
MULTIPLE SCLEROSIS IN CHILDHOOD.
Pages
« first
‹ previous
…
611
612
613
614
615
616
617
618
619
…
next ›
last »